The drugmaker warned that the treatment could cause tumors in the thyroid, including thyroid cancer, warning patients to monitor symptoms such as a lump or swelling in the neck, hoarseness, trouble swallowing or shortness of breath
New research presented at the 2026 ASCO Gastrointestinal Cancers Symposium shows a reduced risk of colorectal cancer among GLP-1 users
Consequently, the current prescribing information for oral semaglutide recommends taking the tablet on an empty stomach with no more than 120 mL/4 oz of water at least 30 min before the first food, drink, or other oral medications of the day [1]
Common early experiences include: Reduced appetite : Many people notice decreased hunger and earlier satiety during meals within days of the first injection or dose Mild gastrointestinal symptoms : Nausea (affecting 2040% of patients), occasional vomiting, or changes in bowel habits are usually mild and transient Injection site reactions : Minor redness, itching, or discomfort at injection sites is common but typically resolves quickly Fatigue : Some individuals report feeling more tired initially as their body adjusts to reduced calorie intake By weeks 24 , appetite suppression typically becomes more pronounced, and patients often find it easier to adhere to portion control and dietary modifications
Antioxidant and cellular protection Glutathione's core role is defending cells against oxidative stress the everyday "rusting" caused by free radicals
